| abstract |
The invention discloses a standard test method for determining the resistance of Mycoplasma gallisepticum to danfloxacin. The dosing schedule for Mycoplasma gallisepticum, the clinical critical value of danfloxacin for Mycoplasma gallisepticum, and the dendrogram developed through the CLSI sensitivity breakpoints to obtain the criteria for determining the resistance of danofloxacin to Mycoplasma gallisepticum; The method of the invention can formulate the standard for determining the resistance of Mycoplasma gallisepticum to darofloxacin, can provide stable drug data support for scientific breeding, can guide clinical drug use more scientifically, and effectively treat chickens suffering from sinusitis and bronchitis It can effectively alleviate the resistance of Mycoplasma gallisepticum to danfloxacin to a certain extent, and protect and maintain the effectiveness of danfloxacin. |